Gut Hormones: Ghrelin and GIP significantly decreased after yerba mate consumption, while GLP-1 remained unchanged
What conditions count for Tier 3 of the Medicare GLP-1 Bridge
The proposed hospital at Acworth is one of many ways Wellstar is improving access to care for communities across Georgia
Current FDA-approved weekly injectable GLP-1 options include: Ozempic (semaglutide, Novo Nordisk) for type 2 diabetes Wegovy (semaglutide, Novo Nordisk) for chronic weight management Mounjaro (tirzepatide, Lilly) for type 2 diabetes Zepbound (tirzepatide, Lilly) for chronic weight management Rybelsus (oral semaglutide, Novo Nordisk) for type 2 diabetes Foundayo (orforglipron, Lilly) oral, for weight management (approved April 2026) For patients who struggle specifically with weekly injections, the most practical currently available option is Foundayo (orforglipron) an oral pill requiring no injection at all
In the same study population, a higher HR was also associated with a greater incidence of new-onset or progressive nephropathy and retinopathy [38]
Med 21 , 2736 (2015)